Financial Times buys controlling stake in Endpoints News

The Financial Times has acquired a controlling stake in Endpoints News, which covers the biopharmaceutical industry, for an undisclosed price.

Endpoints has more than 163,000 subscribers and distributes content via its daily news reports and website, and at in-person and online events.

This acquisition marks a significant milestone in the FT’s expansion in the U.S., where Endpoints is based, and deepens the FT’s coverage of the dynamic biopharma sector.

“We’re thrilled to invest in Endpoints, a fast-growing business with a robust reputation for delivering quality news to audiences across the biopharma ecosystem,” said FT Group CEO John Ridding in a statement. “There is strong alignment between Endpoints and the FT in terms of mission, business model and focus on reader revenues. This acquisition also supports our ambitions to reach new audiences in innovative sectors and grow our footprint in the U.S.”

Endpoints was founded seven years ago.

Chris Roush

Chris Roush was the dean of the School of Communications at Quinnipiac University in Hamden, Connecticut. He was previously Walter E. Hussman Sr. Distinguished Professor in business journalism at UNC-Chapel Hill. He is a former business journalist for Bloomberg News, Businessweek, The Atlanta Journal-Constitution, The Tampa Tribune and the Sarasota Herald-Tribune. He is the author of the leading business reporting textbook "Show me the Money: Writing Business and Economics Stories for Mass Communication" and "Thinking Things Over," a biography of former Wall Street Journal editor Vermont Royster.